# Glucagon Dose-Response in Patients With Post-Bariatric Hypoglycemia

> **NCT06986603** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Joslin Diabetes Center** · enrollment: 28 (estimated)

## Conditions studied

- Hypoglycemia
- Hypoglycemia, Reactive
- Bariatric Surgery

## Interventions

- **DRUG:** Glucagon for Injection (Fresenius Kabi USA)

## Key facts

- **NCT ID:** NCT06986603
- **Lead sponsor:** Joslin Diabetes Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-11-26
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-09-01
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2026-02-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06986603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06986603, "Glucagon Dose-Response in Patients With Post-Bariatric Hypoglycemia". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT06986603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*